Study of Anti-CEA CAR-T + Chemotherapy VS Chemotherapy Alone in Patients With CEA+Pancreatic Cancer & Liver Metastases
Clinical trial NCT04037241 · WITHDRAWN
Trial details
- NCT number
- NCT04037241
- Sponsor
- Sorrento Therapeutics, Inc.
- Status
- WITHDRAWN
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-11-01
- Primary completion
- 2022-01-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.